Created at 9:09 p.m. Aug, 15, 2025
Author:
adavis98
Rationale for change
According to your table, the GINA 2024 guidelines for mild-persistent (which falls under step 2) would be low-dose ICS + formoterol PRN.
Formoterol is a LABA.
Therefore, the answer is "As needed low-dose ICS and LABA"
Current
Suggested
Text
Text
Text
Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources



One by one
Empty field







